Volume 16 Issue 2, June 2022
BioPharma Dealmakers (@bpdealmakers) / Twitter
Article in Nature Biopharma Dealmakers: The key to treating sepsis and septic shock: matching treatment to causal pathophysiology – Adrenomed
Immunophotonics Featured in Nature Biopharma Dealmakers - Immunophotonics
Biopharma Dealmakers | LinkedIn
Biopharma dealmaking in 2019
Nature Reviews - BioPharma Dealmakers is a partnering supplement to Nature Biotechnology and Nature Reviews Drug Discovery featuring the latest on dealmaking opportunities and emerging therapeutic areas. Check out the latest issue
Biopharma Dealmakers
Cellestia's article in Nature Biopharma Deal Makers -
Volume 14 Issue 2, June 2020
Claire Thompson - Head of Business Development - Biopharma Projects - Nature Research (Publishing), at Springer Nature | LinkedIn
Biopharma Dealmakers Supplement January
Volume 16 Issue 3, September 2022
Immunophotonics Featured in Nature Biopharma Dealmakers - Immunophotonics
Publications - Rezolute Bio
2022 Biopharma Dealmakers Media Kit Now Available - Nature Research Partnerships
Immunophotonics Publishes Follow-up Feature in Nature Biopharma Dealmakers - Immunophotonics
BioPharma Dealmakers
Biopharma dealmaking in 2021
Materialien | Minaris Regenerative Medicine
Biopharma Dealmakers
Biopharma Dealmakers
BioPharma Dealmakers (@bpdealmakers) / Twitter
Nature Biopharma Dealmakers: Reshaping the production of DNA-based therapies - Touchlight
A year in biopharma dealmaking
BioPharma Dealmakers (@bpdealmakers) / Twitter
MEDIA KIT 2022
